Published in Neurology on March 01, 1987
Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1. J Biol Chem (2008) 0.79
Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology. Cell Metab (2015) 0.78
A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effect. J Transl Med (2013) 0.77
Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression. J Psychiatry Neurosci (1993) 0.77
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA (1992) 6.96
Palliative medicine: is it really specialist territory? J R Soc Med (1998) 5.46
The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev (2000) 5.40
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Some relations between changes in the linear electrical properties of striated muscle fibers and changes in ultrastructure. J Gen Physiol (1967) 4.53
Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab (2004) 4.48
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab (1997) 4.47
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34
The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology (1995) 3.95
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry (2002) 3.82
Withholding and withdrawal of life support from the critically ill. N Engl J Med (1990) 3.73
Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr (1992) 3.62
New rules on medicines. Vet Rec (1995) 3.49
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med (1998) 3.16
Dissociation of object and spatial visual processing pathways in human extrastriate cortex. Proc Natl Acad Sci U S A (1991) 3.15
Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab (2001) 2.97
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med (1997) 2.73
Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab (1994) 2.71
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1) N Engl J Med (1988) 2.58
Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A (1989) 2.43
Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab (1999) 2.40
Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst (1990) 2.34
Chronic low back pain in general practice: the challenge of the consultation. Fam Pract (1999) 2.32
Face encoding and recognition in the human brain. Proc Natl Acad Sci U S A (1996) 2.31
Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans. J Infect Dis (1998) 2.27
Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology (1998) 2.24
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab (1991) 2.23
Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab (1994) 2.22
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest (1995) 2.20
Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol (1993) 2.20
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Network analysis of cortical visual pathways mapped with PET. J Neurosci (1994) 2.14
Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab (2004) 2.11
Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev (1996) 2.11
Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem (1987) 2.09
Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res (1998) 2.06
Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med (1993) 2.05
Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain (2001) 2.05
"Leaner and less fit" children have a better cardiometabolic profile than their "heavier and more fit" peers: the Healthy Growth Study. Nutr Metab Cardiovasc Dis (2013) 2.04
Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem (1991) 2.01
Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum (1994) 1.97
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N Engl J Med (1988) 1.95
Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest (1996) 1.94
X-chromosome effects on female brain: a magnetic resonance imaging study of Turner's syndrome. Lancet (1993) 1.93
Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry (1996) 1.90
An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol (1984) 1.87
Short sleep duration and obesity: the role of emotional stress and sleep disturbances. Int J Obes (Lond) (2008) 1.86
The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. Arch Neurol (1988) 1.86
Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology (1990) 1.84
The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research Group. Gerontologist (2000) 1.84
Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab (1998) 1.80
Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res (1994) 1.80
Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med (1999) 1.79
Preventing type 2 diabetes after gestational diabetes: women's experiences and implications for diabetes prevention interventions. Diabet Med (2013) 1.79
Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab (1997) 1.79
Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med (2003) 1.78
Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med (1994) 1.78
Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol (1973) 1.75
Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med (1998) 1.74
Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism (2002) 1.71
Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science (1991) 1.70
Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol (1992) 1.70
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A (2000) 1.69
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry (1992) 1.69
Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab (1999) 1.68
Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev (1992) 1.66
Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab (1997) 1.65
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab (1993) 1.65
IL-6 and its circadian secretion in humans. Neuroimmunomodulation (2005) 1.64
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry (2009) 1.64
Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Neuropharmacology (1998) 1.63
The biopsychosocial model of general practice: rhetoric or reality? Br J Gen Pract (1996) 1.62
Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol (1990) 1.62
Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med (1997) 1.61
Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology (1990) 1.61
A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A (1989) 1.61
The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J Virol (2000) 1.60
Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry (2006) 1.60
Expression of TTK, a novel human protein kinase, is associated with cell proliferation. J Biol Chem (1992) 1.59
Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol (1998) 1.59
Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated. J Biol Chem (1990) 1.58
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology (1996) 1.57
Thyroid hormone concentrations in depressed and nondepressed adolescents: group differences and behavioral relations. J Am Acad Child Adolesc Psychiatry (1996) 1.57
Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation (1998) 1.57
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry (1989) 1.56